PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and ...
Blood. 2005 Sep 27; [Epub ahead of print]
PMID: 16189265
Although this paper is based on mast cells, not GIST cells, it is relevant due to the different KIT mutations and corresponding drug sensitivities discussed.
Entrez PubMed

